Concepedia

Nicolas Leupin

NL

Statistics

Publications

20

Citations

1.7K

H-Index

17

Active since

2000

Affiliations

University Hospital of Bern(Current)

University of Bern

Ablynx (Belgium)

SIB Swiss Institute of Bioinformatics

University Hospital of Zurich

Nicolas Leupin is an author at University Hospital of Bern specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2000–2024

20

Publications

20

Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans

Peter Ulrichts, Antonio Guglietta, Torsten Dreier et al. · Journal of Clinical Investigation · 2018 · 382 citations · Full text

, , +17

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

James F. Howard, Vera Bril, Ted M. Burns et al. · Neurology · 2019 · 288 citations · Full text

, , +14

Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents

Carsten Riether, Thomas Pabst, Sabine Höpner et al. · Nature Medicine · 2020 · 211 citations

, , +14

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

Adrian C. Newland, Blanca Sánchez‐González, László Rejtő et al. · American Journal of Hematology · 2019 · 181 citations · Full text

, , +17

Acute Radiation Colitis in Patients Treated With Short-Term Preoperative Radiotherapy for Rectal Cancer

Nicolas Leupin, Jürgen Curschmann, Helmut Kranzbühler et al. · The American Journal of Surgical Pathology · 2002 · 85 citations

, , +17

1–5 of 20